 TAIZHOU, ZHEJIANG, CHINA SAN DIEGO, CA ACCESSWIRE May 19, 2021 Nascent Biotech, Inc. OTCQB:NBIO and BioRay Pharmaceutical Ltd., today announced that Nascent Biotech Nascent or the Company has entered into a license agreement the Agreement with BioRay Pharmaceutical Co Ltd BioRay, thereby granting to BioRay exclusive rights to commercialize Nascents monoclonal antibody, Pritumumab, in international markets, excluding North America and Central America. 